Clinical practice guidance of APASL COVID-19 Task Force is now available.

You can read and download the guidance from This PAGE.

What's New

2025/10/24
The B-Together study explores the potential of bepirovirsen in modulating immune responses to enhance the clearance of HBV-infected hepatocytes.

The B-Together study explores the potential of bepirovirsen in modulating immune responses to enhance the clearance of HBV-infected hepatocytes. This … [Read more]
2025/10/23
This cross-sectional analysis emphasizes the importance of integrated care approaches in managing patients with MASLD and related comorbidities.

Emerging data from the Paracelsus 10,000 Study reveal a significant association between depression and metabolic dysfunction-associated steatotic liver disease (MASLD), … [Read more]
2025/10/21
Do the therapeutic vaccines hold hope for the treatment of hepatitis B ?

Emerging data from the Paracelsus 10,000 Study reveal a significant association between depression and metabolic dysfunction-associated steatotic liver disease (MASLD), … [Read more]
2025/10/20
Please check out the latest article on Hep I !!

Understanding the stage-specific impact of portal hypertension is crucial in optimizing surgical outcomes for hepatocellular carcinoma (HCC). This study provides … [Read more]
2025/10/17
APASL STC 2025 Yangon will be held on December 13-14 !!

Please check out the Scientific Program of APASL STC 2025 Yangon scheduled on December 13-14 !! We are so thrilled … [Read more]

What's New